Generate Biomedicines

(NASDAQ) GENB

Current Price$13.05

Market Cap$1.68B

Since IPO (2026)+4%

5 YearN/A

1 YearN/A

1 Month+6%

Generate Biomedicines Financials at a Glance

Market Cap

$1.68B

Revenue (TTM)

$16.04

Net Income (TTM)

-$106.03

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$13.05

Volume

10,647

Open

$13.23

Price

$13.05

Volume

10,647

Open

$13.23

Previous Close

$13.05

Daily Range

$12.78 - $13.38

52-Week Range

$11.00 - $16.75

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$13.05

Volume

10,647

Open

$13.23

Previous Close

$13.05

Daily Range

$12.78 - $13.38

52-Week Range

$11.00 - $16.75

GENB News

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

Jonathan PoncianoMay 31, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Generate Biomedicines

Industry

Biotechnology

Sector

Health Care

Employees

312

CEO

Michael T. Nally, MBA

Website

generatebiomedicines.com

Headquarters

Somerville, MA 02143, US

GENB Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-7%

Net Income Margin

-6%

Return on Equity

Return on Capital

-95%

Return on Assets

-62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.68B

Shares Outstanding

128.19M

Volume

10.65K

Avg. Volume

530.53K

Financials (TTM)

Gross Profit

$31.89M

Operating Income

-$235.07M

EBITDA

-$208.49M

Operating Cash Flow

-$200.62M

Capital Expenditure

-$3.51M

Free Cash Flow

-$204.13M

Cash & ST Invst.

$221.50M

Total Debt

$68.53M

Generate Biomedicines Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$7.22M

N/A

Gross Profit

$3.95M

N/A

Gross Margin

54.69%

N/A

Market Cap

$1.68B

N/A

Market Cap/Employee

$5.39M

N/A

Employees

312

N/A

Net Income

-$61.45M

N/A

EBITDA

-$60.84M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$451.07M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$51.31M

N/A

Short Term Debt

$14.26M

N/A

Return on Assets

-61.53%

N/A

Return on Invested Capital

-94.79%

N/A

Free Cash Flow

-$84.17M

N/A

Operating Cash Flow

-$80.39M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,580.06+0.00%

^DJIDJI

^DJIDJI$51,032.46+0.01%

^IXICNASDAQ

^IXICNASDAQ$26,972.62+0.00%

BTCBitcoin

BTCBitcoin$73,525.00-0.01%

AAPLAAPL

AAPLAAPL$311.87-0.00%

AMZNAMZN

AMZNAMZN$270.49-0.01%

GOOGGOOG

GOOGGOOG$376.37-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

SOFISoFi Technologies

SOFISoFi Technologies$18.22+0.07%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$84.56+0.01%

Questions About GENB

What is the current price of Generate Biomedicines?

Generate Biomedicines is trading at $13.05 per share.

What is the 52-week range for Generate Biomedicines?

Over the past 52 weeks, Generate Biomedicines has traded between $11.00 and $16.75.

How much debt does Generate Biomedicines have?

As of the most recent reporting period, Generate Biomedicines reported total debt of $65.57M.

How much cash does Generate Biomedicines have on hand?

Generate Biomedicines reported $160.58M in cash and cash equivalents in its most recent financial results.

What is Generate Biomedicines’s dividend yield?

Generate Biomedicines does not currently have a dividend yield.

Generate Biomedicines

Generate Biomedicines Financials at a Glance

GENB News

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Generate Biomedicines

GENB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Generate Biomedicines Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GENB

What is the current price of Generate Biomedicines?

What is the 52-week range for Generate Biomedicines?

How much debt does Generate Biomedicines have?

How much cash does Generate Biomedicines have on hand?

What is Generate Biomedicines’s dividend yield?

Premium Investing Services